INTRODUCTION AND OBJECTIVES:
Male fertility relies on the proper regulation of human adult spermatogonial stem cells (SSCs), which either self-renew or commit to unipotent differentiation (spermatogenesis). The future of male fertility lies in culturing human SSCs, and is currently the core limitation of the field. Mouse SSCs can be cultured, manipulated, and transplanted back into the testis. However, the conditions used to culture mouse SSCs fail to support the growth and germline identity of human SSCs. To better understand human SSC self-renewal and differentiation, and to enable long-term culturing, we aimed to conduct molecular/genomic profiling of human SSCs.
METHODS: First, we derived methods to purify the selfrenewing human SSC (which bear the surface marker SSEA4), and differentiating human spermatogonia (which bear KIT). We profiled RNA/transcription (via bulk and single-cell RNA sequencing), DNA methylation (via whole-genome bisulfite sequencing) and determined the promoters and enhancers that have open chromatin (via ATAC-seq) in SSEA4-enriched SSCs. We also conducted RNA/transcription profiling of differentiating KIT+ spermatogonia to provide comparisons to SSEA4+ SSCs.
RESULTS: Here, we successfully profiled RNA, chromatin and DNA methylation in human SSEA4+ SSCs, and RNA in KIT+ spermatogonia. We identified transcription factors and signaling pathway components that are unique to either SSEA4+ SSCs or KIT+ spermatogonia. Importantly, several factors including receptor/ligand systems and transcription factors appear unique to humans (not utilized in the mouse), results of which inform the biology of human SSC selfrenewal and differentiation, and should inform and guide human SSC cell culturing. Remarkably, we find the core pluripotentcy genes (e.g. OCT4, SOX2, NANOG) repressed in SSCs, with portion apparently poised for activation in SSCs by open chromatin, creating a condition of 'latent' pluripotency likely to impact their developmental potential.
CONCLUSIONS: Human SSCs have been extensively profiled, revealing signaling and transcription factor pathways of likely importance. Latent pluripotency in SSCs may enable rapid activation of pluripotency following fertilization, but may also create susceptibiliy to forming germ cell tumors e enabling their plasticity to form tumors with all three germ layers. Overall, our findings provide insights into understanding unipotency and pluripotency in human SSCs, possible mechanisms for germ cell tumor formation, and guidance for in vitro culturing of human SSCs.
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PD08-04 WHOLE EXOME SEQUENCING OF A CONSANGUINEOUS TURKISH FAMILY IDENTIFIES A MUTATION IN X-LINKED FHL1 IN BROTHERS WITH MALE FACTOR INFERTILITY
Raul Clavijo*, Samuel Cohen, anthony griswold, Miami, FL; Emre Bakircioglu, Istanbul, Turkey; Ranjith Ramasamy, Miami, FL INTRODUCTION AND OBJECTIVES: Up to 80% of patients with a diagnosis of nonobstructive azoospermia (NOA) have a negative result on genetic testing. We sequenced the exomes of a consanguineous Turkish family comprised of the mother and father, who are cousins, and their four sons. Two sons had NOA and two had chest wall deformities and oligospermia. Standard genetic testing revealed no karyotype abnormalities or Y microdeletions. Using whole exome sequencing (WES) data and homozygosity mapping we sought to investigate the genetic cause of abnormal semen parameters in the sons.
METHODS: Extraction of DNA was performed from blood samples followed by whole exome sequencing. Variants were annotated using the ANNOVAR software tool. The filter based annotation feature was used to assess variants for rarity, deleterious nature, conservation, and confirmed familial segregation as well as absence in the control population.
RESULTS: A non-synonymous mutation in "four-and-a-half lim domains 1" (FHL1) was identified in this consanguineous family from Turkey. This mutation in exon 6 (Xchr:135292164 G>A) of FHL1 is a nonsynonymous SNP and likely a disease-causing mutation as it is predicted to be damaging (SIFT 0.026, mutation taster score 1/D, and Polyphen2 0.846), is a rare variant (ExAC allele frequency of 1.11%), segregates with the disease, and is highly conserved (GERP 5.57). Family segregation of the variants showed the presence of the homozygous mutation in the brothers with NOA and low sperm counts, heterozygous mutation in the mother, and homozygous wild type in the father indicating an X-linked inheritance pattern.
CONCLUSIONS: Using WES, we identified an X linked mutation in FHL1 as a likely disease-causing variant in a Turkish family with two sons diagnosed with NOA. Our data reinforce the clinical role of WES in the molecular diagnosis of highly heterogeneous genetic diseases, where conventional genetic approaches have previously failed to define a genetic diagnosis. INTRODUCTION AND OBJECTIVES: Non-obstructive azoospermia (NOA) is a cause of male infertility secondary to genetically driven defects in spermatogenesis. Testicular sperm extraction (TESE) is successful in identifying small number of sperm in 50% of men with NOA. During TESE, predominantly collapsed seminiferous tubules (ST) are identified with rare areas of dilated STs that are more likely to harbor viable sperm. Hence we hypothesize that miRNA regulated control of mRNA expression along STs leads to optimal environments for spermatogenesis within the human testis.
METHODS: STs were obtained from 7 patients, including 3 with NOA, and 2 patients with Sertoli-cell only (SCO). In the three NOA patients, single STs were cut based on the differences in diameter along the same ST into: full/dilated or empty/collapsed tubules. Quantitative PCR was performed on all tubules for GFRa1 and values expressed per vimentin and clusterin. ACTB was used as a housekeeping gene. Expression of GFRa1 was corrected for number of Vol. 197, No. 4S, Supplement, Friday, May 12, 2017 THE JOURNAL OF UROLOGY â e189
